BridgeMD
New treatment option for Parkinson Disease
Official title Effect of Vitamin D3 Supplementation on Cardiac Autonomic Nerve Function in Male Parkinson's Disease Patients With Hypovitaminosis D
ClinicalTrials.gov ID: NCT07084597
What this study is testing
- What it's testing
- The goal of this clinical trial is to see the effect of vitamin D3 supplementation on cardiac autonomic nerve function in male Parkinson's disease patients with hypovitaminosis D Main questions it aims to answer are: 1. Does vitamin D improves heart rate variability(HRV) in male Parkinson's disease patients ?
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 51 to 70, men only
You may be able to join if
- Male patients with of Parkinson's disease diagnosed by neurologist with unilateral or bilateral involvement and mild to moderate disability according...
- Age: 51-70 years
- BMI: 18.5-24.9 kg/m2
- Vitamin D3 deficient or insufficient
- On Levodopa medication
You likely can't join if
- Patients with a history of drug abuse including alcoholism.
- Patients on following drugs will be excluded-
- Antioxidant vitamin supplements
- Lipid lowering medications
- Antihypertensive drug
- Anti-arrhythmic drug
See the full eligibility criteria
- Male patients with of Parkinson's disease diagnosed by neurologist with unilateral or bilateral involvement and mild to moderate disability according to Hoehn and Yahr (H-Y) scale (I-III)
- Age: 51-70 years
- BMI: 18.5-24.9 kg/m2
- Vitamin D3 deficient or insufficient
- On Levodopa medication
- Patients with a history of drug abuse including alcoholism.
- Patients on following drugs will be excluded-
- Antioxidant vitamin supplements
- Lipid lowering medications
- Antihypertensive drug
- Anti-arrhythmic drug
- Sedatives
- All patients with the history of or clinical manifestation of currently suffering from following diseases \& condition will be excluded
- Severe Cardiovascular disorders
- Severe neurological disorders
- Severe Respiratory disorders
- Severe Renal insufficiency (S. Creatinine \> 1.5 mg/dl, Acute or chronic kidney disease)
- Severe Endocrine disease
- Severe Arthritis
- Severe Liver diseases
- Severe Neoplastic disease
- Severe Psychiatric disorder
- Current use of iron, zinc, calcium, magnesium and multivitamin supplementation
- Already performing yoga or breathing exercise
- Hypercalcemia
The study team makes the final eligibility decision.
Where it's taking place
- Dhaka, Shahbag, Bangladesh
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 51 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Dhaka, Shahbag, Bangladesh. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.